Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDActual EPS
Predictive Oncology Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 1 | -$1.35 | -$1.35 | -$1.35 |
| Q2 2025 | 1 | -$1.35 | -$1.35 | -$1.35 |
| Q3 2025 | 1 | -$1.35 | -$1.35 | -$1.35 |
| Q4 2025 | 1 | $0.90 | $0.90 | $0.90 |
Predictive Oncology Inc. Earnings Date And Information
Predictive Oncology Inc. last posted its earnings results on Friday, November 14th, 2025. The company reported $-4.52 earnings per share for the quarter, missing analysts' consensus estimates of $-1.35 by $3.17. The company had revenue of 3.62 K for the quarter and had revenue of 1.62 M for the year. Predictive Oncology Inc. has generated $-2 earnings per share over the last year ($-2.240000112 diluted earnings per share) and currently has a price-to-earnings ratio of -5.79. Predictive Oncology Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, April 8th, 2026 based on prior year's report dates.
Predictive Oncology Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/14/2025 | Q3 2025 | -$1.35 | -$107.25 | -105.9 | $1.50 M | $3.62 K |
| 08/13/2025 | Q2 2025 | -$1.35 | -$0.23 | 1.12 | $1.50 M | $2.68 K |
| 05/14/2025 | Q1 2025 | -$0.09 | -$0.34 | -0.25 | N/A | $110.31 K |
| 03/31/2025 | Q4 2024 | N/A | -$0.40 | N/A | N/A | $611.59 K |
| 11/12/2024 | Q3 2024 | -$0.32 | -$0.61 | -0.29 | $500.00 K | $345.69 K |
| 08/13/2024 | Q2 2024 | N/A | -$0.68 | N/A | $278.72 K | $278.72 K |
| 05/14/2024 | Q1 2024 | N/A | -$1.04 | N/A | N/A | $419.65 K |
| 03/28/2024 | Q4 2023 | N/A | -$0.86 | N/A | N/A | $335.03 K |
| 11/13/2023 | Q3 2023 | N/A | -$0.68 | N/A | N/A | $676.63 K |
| 08/10/2023 | Q2 2023 | N/A | -$0.98 | N/A | N/A | $490.11 K |
| 05/15/2023 | Q1 2023 | N/A | -$0.86 | N/A | N/A | $239.90 K |
| 03/21/2023 | Q4 2022 | -$0.06 | -$2.01 | -1.95 | $500.00 K | $363.47 K |
| 11/10/2022 | Q3 2022 | -$0.20 | -$1.04 | -0.84 | $4.00 M | $455.83 K |
| 08/11/2022 | Q2 2022 | -$0.60 | -$2.89 | -2.29 | $2.00 M | $371.59 K |
| 05/12/2022 | Q1 2022 | -$0.80 | -$1.02 | -0.22 | $1.00 M | $314.57 K |
| 03/31/2022 | Q4 2021 | -$0.23 | -$2.42 | -2.19 | $2.50 M | $476.49 K |
| 11/10/2021 | Q3 2021 | -$1.00 | -$1.66 | -0.66 | $600.00 K | $313.66 K |
| 08/11/2021 | Q2 2021 | -$1.40 | -$1.00 | 0.4 | $600.00 K | $350.21 K |
| 05/12/2021 | Q1 2021 | -$0.09 | -$2.20 | -2.11 | $350.00 K | $280.32 K |
| 03/15/2021 | Q4 2020 | -$0.18 | -$12.75 | -12.57 | $350.00 K | $293.79 K |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Predictive Oncology Inc. Earnings: FAQ's
Predictive Oncology Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, April 8th, 2026 based offlast year's report dates.
The conference call for Predictive Oncology Inc.'s latest earnings report can be listened to online.
The conference call transcript for Predictive Oncology Inc.'s latest earnings report can be read online.
Predictive Oncology Inc. (:POAI) has a recorded annual revenue of $1.62 M.
Predictive Oncology Inc. (:POAI) has a recorded net income of $-12,201,261.Predictive Oncology Inc. has generated $-2.240000112 earnings per share over the last four quarters.
Predictive Oncology Inc. (:POAI) has a price-to-earnings ratio of -5.79 and price/earnings-to-growth ratio is -0.26.